Therapeutic impact of cholecalciferol in patients with psychiatric disorders receiving olanzapine

Somayeh Kaviyani ¹ * , Mohammad Bahadoram ², Gholamreza Houshmand ³, Samaneh Bahadoram ²

Cited by CrossRef: 2

1- Abolghasemi A, Manca C, Iannotti F, Shen M, Leblanc N, Lacroix S, Martin C, Flamand N, Di Marzo V, Silvestri C. Assessment of the Effects of Dietary Vitamin D Levels on Olanzapine-Induced Metabolic Side Effects: Focus on the Endocannabinoidome-Gut Microbiome Axis. IJMS. 2021;22(22):12361 [Crossref]

2- Zhou Z, Nagashima T, Toda C, Kobayashi M, Suzuki T, Nagayasu K, Shirakawa H, Asai S, Kaneko S. Vitamin D supplementation is effective for olanzapine-induced dyslipidemia. Front Pharmacol. 2023;14 [Crossref]

Submit Your Paper Abstracting and Indexing Contact Us Self-Archiving Open Access and Copyright Author's Agreement Form Publication Fee Archive

Indexing Information

This journal follows the guidelines of COPE

Follower of the International Committee of Medical Journal Editors

We are follower of World Association of Medical Editors